Clinical Trials
54 trialsNCT05255653 2026-05-15
RAINBO
Leiden University Medical Center
Phase 2/3 Recruiting
NCT05538897 2026-05-13
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT06979596 2026-05-13
OMAHA-015
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT07462663 2026-05-13
SHAPE-ENDO
Hospital Universitari de Bellvitge
Phase 4 Not yet recruiting
NCT07543536 2026-04-22
MEGA-TACT-BC3
Sun Yat-sen University
Phase 3 Not yet recruiting
NCT04939090 2026-04-13
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT07319429 2026-03-13
FEMUS
Fudan University
Phase 2/3 Recruiting
NCT07436793 2026-02-27
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
New Mexico Cancer Research Alliance
Phase 2 Not yet recruiting
NCT06671548 2026-02-02
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Qilu Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT04576104 2026-01-21
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer
Northwestern University
Phase 2 Active not recruiting
NCT03671811 2026-01-06
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
City of Hope Medical Center
Phase 2 Active not recruiting
NCT06998758 2025-12-12
MATRIX
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Recruiting
NCT07254416 2025-11-28
A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Not yet recruiting
NCT04491643 2025-08-11
Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma
Fudan University
Phase 2 Completed
NCT05316467 2025-08-11
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
Fudan University
Phase 2/3 Recruiting
NCT05247268 2025-04-06
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
Fudan University
Phase 2 Recruiting
NCT06549855 2024-08-12
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Peking University People's Hospital
Phase NA Not yet recruiting
NCT05913427 2024-08-01
PESETA
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase 2 Recruiting
NCT06500234 2024-07-15
Nutrition Impact on Immunotherapy of Cancer
Qingdao Central Hospital
Phase 3 Recruiting
NCT06417736 2024-05-16
Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting
NCT03306472 2024-01-30
PIONEER
Cambridge University Hospitals NHS Foundation Trust
Phase 2 Completed
NCT05332483 2023-11-03
MA-EEC
Sunnybrook Health Sciences Centre
Phase 1 Terminated
NCT03283488 2023-07-07
Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.
University of Sao Paulo
Phase 2 Completed
NCT03077698 2022-06-07
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
Xenetic Biosciences, Inc.
Phase 2 Terminated
NCT05380479 2022-05-18
Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2 Unknown
NCT02269670 2022-04-05
Phase II Study of Everolimus Beyond Progression
Emory University
Phase 2 Terminated
NCT00006799 2021-09-09
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer
Wake Forest University Health Sciences
Phase 3 Completed
NCT00031785 2021-09-09
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Wake Forest University Health Sciences
Phase 3 Completed
NCT00070148 2021-09-09
Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
Wake Forest University Health Sciences
Phase 3 Completed
NCT03241914 2020-11-20
Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
Fudan University
Phase 2/3 Completed
NCT00503581 2020-11-03
Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
GOG Foundation
Phase 2 Terminated
NCT04430361 2020-06-12
the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
Henan Cancer Hospital
Phase 2 Unknown
NCT03024580 2019-08-15
MEGA
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
NCT00729586 2019-07-23
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00910091 2019-01-30
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
Ipsen
Phase 2 Completed
NCT03777930 2018-12-19
The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol
Shenzhen Fifth People's Hospital
Phase 4 Unknown
NCT00483327 2018-04-04
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
NYU Langone Health
Phase 2 Completed
NCT02980653 2017-01-18
Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT
TTY Biopharm
Phase 2 Unknown
NCT00031707 2016-07-14
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00637728 2016-06-23
Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients
Par Pharmaceutical, Inc.
Phase 3 Terminated
NCT00637806 2016-05-02
Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension
Par Pharmaceutical, Inc.
Phase 3 Terminated
NCT02619266 2015-12-04
The Safety and Effect Study of Acupuncture for Anorexia in Patients With Gastrointestinal Tract and Lung Cancers
Xinqiao Hospital of Chongqing
Phase 2/3 Unknown
NCT01200602 2015-11-25
Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy
Mayo Clinic
Phase 2 Terminated
NCT00005975 2015-11-18
S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer
SWOG Cancer Research Network
Phase 3 Completed
NCT00739830 2015-07-01
Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01943058 2014-09-10
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer
University of Southern California
Phase 2 Withdrawn
NCT00066248 2014-02-03
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
University of South Florida
Phase 2 Completed
NCT01501396 2014-02-03
Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite
Washington University School of Medicine
Phase 2 Withdrawn
NCT00002465 2013-11-06
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00041275 2013-09-20
Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Completed